packageCarisbamate

carisbamate

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Carisbamate is an investigational antiepileptic drug that was developed for the treatment of epilepsy. It was never approved; a marketing application in the European Union was withdrawn, so it remains an investigational compound.

Summary written by glm-5.3-flash from Wikidata Q76393597 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:carisbamate
ATC codes:N03AX19
DrugBank:DB12338
PubChem CID:6918474
ChEBI:135966
Wikidata:Q76393597
formula:C9H10ClNO3
molar mass:215.633 g/mol (PubChem CID 6918474)
logP:1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown